Cargando…
Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction
Interleukin 6 receptor (IL6R) inhibitor, tocilizumab, has been effectively used in the treatment of cytokine release syndrome in patients receiving chimeric antigen receptor T-cell therapy. Here we present a patient with chronic myelomonocytic leukemia (CMML) who developed a steroid refractory, post...
Autores principales: | Melody, Megan, Butts, Emily, Menke, David, Landolfo, Kevin, Oken, Keith, Sher, Taimur, Khurana, Sharad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672312/ https://www.ncbi.nlm.nih.gov/pubmed/33240789 http://dx.doi.org/10.1016/j.lrr.2020.100228 |
Ejemplares similares
-
Leukemoid like reaction in a post CABG patient
por: Padmakumar, G, et al.
Publicado: (2014) -
Eosinophilia with leukemoid reaction secondary to Sarcoptes scabiei
por: Sánchez-Flores, Xavier, et al.
Publicado: (2020) -
Leukemoid reaction in megaloblastic anemia of the puerperium: An unusual cause
por: Pahadiya, Hans Raj, et al.
Publicado: (2017) -
Esophageal adenocarcinoma with leukemoid reaction: a case report
por: Yu, Ge, et al.
Publicado: (2019) -
Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours
por: Abukhiran, Ibrahim A, et al.
Publicado: (2020)